Literature DB >> 11046035

Allergen-induced airway hyperreactivity is diminished in CD81-deficient mice.

J Deng1, V P Yeung, D Tsitoura, R H DeKruyff, D T Umetsu, S Levy.   

Abstract

We demonstrated previously that CD81(-/-) mice have an impaired Th2 response. To determine whether this impairment affected allergen-induced airway hyperreactivity (AHR), CD81(-/-) BALB/c mice and CD81(+/+) littermates were sensitized i.p. and challenged intranasally with OVA. Although wild type developed severe AHR, CD81(-/-) mice showed normal airway reactivity and reduced airway inflammation. Nevertheless, OVA-specific T cell proliferation was similar in both groups of mice. Analysis of cytokines secreted by the responding CD81(-/-) T cells, particularly those derived from peribronchial draining lymph nodes, revealed a dramatic reduction in IL-4, IL-5, and IL-13 synthesis. The decrease in cytokine production was not due to an intrinsic T cell deficiency because naive CD81(-/-) T cells responded to polyclonal Th1 and Th2 stimulation with normal proliferation and cytokine production. Moreover, there was an increase in T cells and a decrease in B cells in peribronchial lymph nodes and in spleens of immunized CD81(-/-) mice compared with wild-type animals. Interestingly, OVA-specific Ig levels, including IgE, were similar in CD81(-/-) and CD81(+/+) mice. Thus, CD81 plays a role in the development of AHR not by influencing Ag-specific IgE production but by regulating local cytokine production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046035     DOI: 10.4049/jimmunol.165.9.5054

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Sequence-specific interaction between the disintegrin domain of mouse ADAM 3 and murine eggs: role of beta1 integrin-associated proteins CD9, CD81, and CD98.

Authors:  Y Takahashi; D Bigler; Y Ito; J M White
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization.

Authors:  Hong-Xing Wang; Tatiana V Kolesnikova; Carilee Denison; Steven P Gygi; Martin E Hemler
Journal:  J Cell Sci       Date:  2011-07-19       Impact factor: 5.285

Review 3.  Function of the tetraspanin molecule CD81 in B and T cells.

Authors:  Shoshana Levy
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

4.  Mutation of juxtamembrane cysteines in the tetraspanin CD81 affects palmitoylation and alters interaction with other proteins at the cell surface.

Authors:  Caroline Delandre; Taryn R Penabaz; A Lorena Passarelli; Stephen K Chapes; Rollie J Clem
Journal:  Exp Cell Res       Date:  2009-03-25       Impact factor: 3.905

5.  Tetraspanins in mast cells.

Authors:  Martin Köberle; Susanne Kaesler; Wolfgang Kempf; Florian Wölbing; Tilo Biedermann
Journal:  Front Immunol       Date:  2012-05-07       Impact factor: 7.561

Review 6.  Specific tetraspanin functions.

Authors:  M E Hemler
Journal:  J Cell Biol       Date:  2001-12-24       Impact factor: 10.539

7.  Human CD81 directly enhances Th1 and Th2 cell activation, but preferentially induces proliferation of Th2 cells upon long-term stimulation.

Authors:  Holden T Maecker
Journal:  BMC Immunol       Date:  2003-02-19       Impact factor: 3.615

Review 8.  Tetraspanins and Transmembrane Adaptor Proteins As Plasma Membrane Organizers-Mast Cell Case.

Authors:  Ivana Halova; Petr Draber
Journal:  Front Cell Dev Biol       Date:  2016-05-10

9.  Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

Authors:  Yoshito Takeda; Isao Tachibana; Kenji Miyado; Masatoshi Kobayashi; Toru Miyazaki; Toshiki Funakoshi; Hiromi Kimura; Hiroyuki Yamane; Yoshiyuki Saito; Hiroyuki Goto; Tsutomu Yoneda; Mitsuhiro Yoshida; Toru Kumagai; Tadashi Osaki; Seiji Hayashi; Ichiro Kawase; Eisuke Mekada
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

Review 10.  Antitumor Immunity Is Controlled by Tetraspanin Proteins.

Authors:  Fleur Schaper; Annemiek B van Spriel
Journal:  Front Immunol       Date:  2018-05-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.